RhumbLine Advisers’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $173M | Sell |
2,213,044
-28,248
| -1% | -$2.28M | 0.13% | 113 |
|
|
2026
Q1 | $194M | Sell |
2,241,292
-40,246
| -2% | -$3.86M | 0.17% | 95 |
|
|
2025
Q4 | $219M | Sell |
2,281,538
-60,820
| -3% | -$5.91M | 0.18% | 89 |
|
|
2025
Q3 | $223M | Sell |
2,342,358
-19,934
| -0.8% | -$1.83M | 0.18% | 92 |
|
|
2025
Q2 | $206M | Sell |
2,362,292
-39,315
| -2% | -$3.33M | 0.18% | 94 |
|
|
2025
Q1 | $216M | Sell |
2,401,607
-141,331
| -6% | -$12.6M | 0.2% | 86 |
|
|
2024
Q4 | $203M | Buy |
2,542,938
+7,596
| +0.3% | +$658K | 0.18% | 90 |
|
|
2024
Q3 | $228M | Sell |
2,535,342
-103,258
| -4% | -$8.69M | 0.21% | 79 |
|
|
2024
Q2 | $208M | Buy |
2,638,600
+391
| +0% | +$32.1K | 0.2% | 87 |
|
|
2024
Q1 | $230M | Sell |
2,638,209
-20,887
| -0.8% | -$1.78M | 0.22% | 81 |
|
|
2023
Q4 | $219M | Sell |
2,659,096
-22,411
| -0.8% | -$1.71M | 0.23% | 80 |
|
|
2023
Q3 | $210M | Buy |
2,681,507
+13,950
| +0.5% | +$1.17M | 0.24% | 71 |
|
|
2023
Q2 | $235M | Buy |
2,667,557
+29,845
| +1% | +$2.57M | 0.26% | 63 |
|
|
2023
Q1 | $213M | Buy |
2,637,712
+89,648
| +4% | +$7.31M | 0.26% | 70 |
|
|
2022
Q4 | $198M | Buy |
2,548,064
+131,539
| +5% | +$10.7M | 0.27% | 75 |
|
|
2022
Q3 | $195M | Buy |
2,416,525
+57,210
| +2% | +$5.14M | 0.29% | 63 |
|
|
2022
Q2 | $212M | Buy |
2,359,315
+94,365
| +4% | +$9.56M | 0.31% | 58 |
|
|
2022
Q1 | $251M | Buy |
2,264,950
+93,462
| +4% | +$9.87M | 0.32% | 51 |
|
|
2021
Q4 | $225M | Buy |
2,171,488
+54,698
| +3% | +$6.33M | 0.28% | 64 |
|
|
2021
Q3 | $265M | Sell |
2,116,790
-50,125
| -2% | -$6.49M | 0.36% | 47 |
|
|
2021
Q2 | $269M | Sell |
2,166,915
-102,718
| -5% | -$12.9M | 0.35% | 47 |
|
|
2021
Q1 | $268M | Sell |
2,269,633
-139,885
| -6% | -$16.4M | 0.36% | 47 |
|
|
2020
Q4 | $282M | Buy |
2,409,518
+8,301
| +0.3% | +$914K | 0.39% | 46 |
|
|
2020
Q3 | $250M | Sell |
2,401,217
-72,015
| -3% | -$7.23M | 0.39% | 48 |
|
|
2020
Q2 | $227M | Buy |
2,473,232
+88,436
| +4% | +$8.48M | 0.38% | 49 |
|
|
2020
Q1 | $215M | Buy |
2,384,796
+44,797
| +2% | +$4.77M | 0.45% | 38 |
|
|
2019
Q4 | $265M | Buy |
2,339,999
+23,553
| +1% | +$2.58M | 0.44% | 35 |
|
|
2019
Q3 | $252M | Buy |
2,316,446
+60,662
| +3% | +$6.33M | 0.46% | 34 |
|
|
2019
Q2 | $220M | Sell |
2,255,784
-46,569
| -2% | -$4.25M | 0.41% | 38 |
|
|
2019
Q1 | $210M | Sell |
2,302,353
-84,838
| -4% | -$7.59M | 0.41% | 42 |
|
|
2018
Q4 | $217M | Buy |
2,387,191
+50,038
| +2% | +$4.68M | 0.47% | 34 |
|
|
2018
Q3 | $230M | Sell |
2,337,153
-60,133
| -3% | -$5.56M | 0.44% | 40 |
|
|
2018
Q2 | $205M | Sell |
2,397,286
-49,758
| -2% | -$4.16M | 0.41% | 42 |
|
|
2018
Q1 | $196M | Buy |
2,447,044
+3,781
| +0.2% | +$312K | 0.41% | 42 |
|
|
2017
Q4 | $197M | Buy |
2,443,263
+27,156
| +1% | +$2.17M | 0.4% | 44 |
|
|
2017
Q3 | $188M | Buy |
2,416,107
+55,903
| +2% | +$4.64M | 0.41% | 43 |
|
|
2017
Q2 | $209M | Buy |
2,360,204
+3,031
| +0.1% | +$256K | 0.48% | 37 |
|
|
2017
Q1 | $190M | Buy |
2,357,173
+122,793
| +5% | +$9.59M | 0.44% | 37 |
|
|
2016
Q4 | $159M | Buy |
2,234,380
+89,810
| +4% | +$7.06M | 0.4% | 41 |
|
|
2016
Q3 | $185M | Buy |
2,144,570
+71,083
| +3% | +$6.19M | 0.51% | 35 |
|
|
2016
Q2 | $180M | Buy |
2,073,487
+122,326
| +6% | +$9.89M | 0.53% | 34 |
|
|
2016
Q1 | $146M | Buy |
1,951,161
+132,955
| +7% | +$10M | 0.45% | 40 |
|
|
2015
Q4 | $140M | Buy |
1,818,206
+2,980
| +0.2% | +$224K | 0.45% | 40 |
|
|
2015
Q3 | $122M | Sell |
1,815,226
-77,176
| -4% | -$5.68M | 0.41% | 45 |
|
|
2015
Q2 | $140M | Sell |
1,892,402
-386,604
| -17% | -$29.5M | 0.45% | 42 |
|
|
2015
Q1 | $178M | Buy |
2,279,006
+546,463
| +32% | +$41.4M | 0.51% | 37 |
|
|
2014
Q4 | $125M | Sell |
1,732,543
-43,286
| -2% | -$3.01M | 0.36% | 56 |
|
|
2014
Q3 | $110M | Sell |
1,775,829
-58,437
| -3% | -$3.72M | 0.33% | 60 |
|
|
2014
Q2 | $117M | Sell |
1,834,266
-49,117
| -3% | -$2.98M | 0.34% | 57 |
|
|
2014
Q1 | $116M | Sell |
1,883,383
-62,299
| -3% | -$3.63M | 0.34% | 57 |
|
|
2013
Q4 | $112M | Sell |
1,945,682
-72,529
| -4% | -$4.11M | 0.33% | 59 |
|
|
2013
Q3 | $107M | Buy |
2,018,211
+6,683
| +0.3% | +$360K | 0.33% | 59 |
|
|
2013
Q2 | $104M | Buy |
+2,011,528
| New | +$99.4M | 0.33% | 59 |
|
Other funds holding MDT
RhumbLine Advisers's MDT Position: Q2 2026 in Review
RhumbLine Advisers reduced its Medtronic (MDT) stake by 1.3% in Q2 2026, selling an estimated $2.28M and leaving 2,213,044 shares worth $173M. The position accounts for 0.13% of the portfolio, ranked #113.
RhumbLine Advisers first reported a position in MDT in Q2 2013 and has held it in 53 quarters since. The position peaked at $282M in Q4 2020. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- RhumbLine Advisers held 2,213,044 shares of Medtronic worth $173M as of Q2 2026.
- RhumbLine Advisers sold 28,248 Medtronic shares in Q2 2026, an estimated $2.28M.
- Medtronic made up 0.13% of RhumbLine Advisers's portfolio in Q2 2026, its #113 holding.
- RhumbLine Advisers first reported a position in Medtronic in Q2 2013 and has held it in 53 quarters since.
- RhumbLine Advisers's Medtronic position peaked at $282M in Q4 2020.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.